» Articles » PMID: 15640801

CD28 Costimulation of Developing Thymocytes Induces Foxp3 Expression and Regulatory T Cell Differentiation Independently of Interleukin 2

Overview
Journal Nat Immunol
Date 2005 Jan 11
PMID 15640801
Citations 265
Authors
Affiliations
Soon will be listed here.
Abstract

Efficient generation of regulatory T cells (T(reg) cells) in the thymus requires CD28 costimulation, but it is not known why. Here, molecular mapping of CD28 costimulation showed that T(reg) cell generation requires a motif that binds the tyrosine kinase Lck, precisely the same motif that is required for CD28 costimulation of interleukin 2 production. Nevertheless, CD28 costimulation provides more than interleukin 2 to developing T(reg) cells, as CD28 costimulation of T cell receptor-signaled double-positive thymocytes induced expression of Foxp3, considered to be the T(reg) 'master gene', as well as GITR and CTLA-4, two proteins expressed on T(reg) cells. Thus, CD28 costimulation directly signals developing thymocytes to express Foxp3 and to initiate the T(reg) cell differentiation program.

Citing Articles

Analysis of the progression of cervical cancer in a low-and-middle-income country: From pre-malignancy to invasive disease.

Robinson E, Rodriguez I, Argueta V, Xie Y, Lou H, Milano R Tumour Virus Res. 2024; 19():200299.

PMID: 39672307 PMC: 11729683. DOI: 10.1016/j.tvr.2024.200299.


The 'T paradox' in inflammatory arthritis.

Schnell J, Briviesca R, Kim T, Charbonnier L, Henderson L, van Wijk F Nat Rev Rheumatol. 2024; 21(1):9-21.

PMID: 39653758 DOI: 10.1038/s41584-024-01190-w.


The Function of Ubiquitination in T-Cell Development.

Peng Z, Zhang H, Hu H Adv Exp Med Biol. 2024; 1466:135-159.

PMID: 39546141 DOI: 10.1007/978-981-97-7288-9_10.


Skewed epithelial cell differentiation and premature aging of the thymus in the absence of vitamin D signaling.

Artusa P, Nguyen Yamamoto L, Barbier C, Valbon S, Aghazadeh Habashi Y, Djambazian H Sci Adv. 2024; 10(39):eadm9582.

PMID: 39321290 PMC: 11423877. DOI: 10.1126/sciadv.adm9582.


Toxicity in the era of immune checkpoint inhibitor therapy.

Keam S, Turner N, Kugeratski F, Rico R, Colunga-Minutti J, Poojary R Front Immunol. 2024; 15:1447021.

PMID: 39247203 PMC: 11377343. DOI: 10.3389/fimmu.2024.1447021.